Industry: Medical Devices & Consumables
Published Date: 2025-08-01
Pages: 78 Pages
Report ld: 4828495
Request Sample
Customized Report
Fungal (1-3)-β-D Glucan Detection Kit Market Size(US$)

CAGR 2025-2031
13.9%
Market Size,2031
USD 135
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Fungal (1-3)-β-D Glucan Detection Kit market size was US$ 55 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 13.9% during the forecast period 2025-2031.
By 2025, the evolving U.S. tariff policy is poised to inject considerable uncertainty into the global economic landscape. This report delves into the latest U.S. tariff measures and the corresponding policy responses across the globe, evaluating their impacts on Fungal (1-3)-β-D Glucan Detection Kit market competitiveness, regional economic performance, and supply chain configurations.
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
The North America Fungal (1-3)-β-D Glucan Detection Kit market size was US$ million in 2024, while Europe was US$ million. The proportion of the North America was % in 2024, while Europe percentage was %, and it is predicted that Europe share will reach % in 2031, trailing a CAGR of % through the analysis period.
The global key manufacturers of Fungal (1-3)-β-D Glucan Detection Kit include Associates of Cape Cod, Era Biology, Dynamiker Biotechnology, Zhanjiang A&C Biological, Xiamen Bioendo Technology, Zhanjiang Bokang Marine Biological, Fuzhou XinBei Biochemical Industrial, Zhuhai DL Biotech, Autobio Diagnostics, etc. In 2024, the global top five players occupied for a share approximately % in terms of revenue.
In North America, in terms of sales volume, in 2024, the top three players hold a share about %, while in Europe, top three players hold a share nearly %.
The global Fungal (1-3)-β-D Glucan Detection Kit market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Fungal (1-3)-β-D Glucan Detection Kit market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Photometric in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Laboratory in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Fungal (1-3)-β-D Glucan Detection Kit value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Fungal (1-3)-β-D Glucan Detection Kit Product Scope
1.2 Fungal (1-3)-β-D Glucan Detection Kit by Type
1.2.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales by Type (2020 & 2024 & 2031)
1.2.2 Kinetic Turbidimetric
1.2.3 Photometric
1.2.4 Colorimetric
1.2.5 Other
1.3 Fungal (1-3)-β-D Glucan Detection Kit by Application
1.3.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Hospital
1.3.3 Laboratory
1.4 Global Fungal (1-3)-β-D Glucan Detection Kit Market Estimates and Forecasts (2020-2031)
1.4.1 Global Fungal (1-3)-β-D Glucan Detection Kit Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Fungal (1-3)-β-D Glucan Detection Kit Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Fungal (1-3)-β-D Glucan Detection Kit Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Fungal (1-3)-β-D Glucan Detection Kit Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Fungal (1-3)-β-D Glucan Detection Kit Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales Market Share by Region (2020-2025)
2.2.2 Global Fungal (1-3)-β-D Glucan Detection Kit Revenue Market Share by Region (2020-2025)
2.3 Global Fungal (1-3)-β-D Glucan Detection Kit Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Fungal (1-3)-β-D Glucan Detection Kit Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Fungal (1-3)-β-D Glucan Detection Kit Market Size and Prospective (2020-2031)
2.4.2 Europe Fungal (1-3)-β-D Glucan Detection Kit Market Size and Prospective (2020-2031)
2.4.3 China Fungal (1-3)-β-D Glucan Detection Kit Market Size and Prospective (2020-2031)
2.4.4 Japan Fungal (1-3)-β-D Glucan Detection Kit Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Fungal (1-3)-β-D Glucan Detection Kit Historic Market Review by Type (2020-2025)
3.1.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales by Type (2020-2025)
3.1.2 Global Fungal (1-3)-β-D Glucan Detection Kit Revenue by Type (2020-2025)
3.1.3 Global Fungal (1-3)-β-D Glucan Detection Kit Price by Type (2020-2025)
3.2 Global Fungal (1-3)-β-D Glucan Detection Kit Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales Forecast by Type (2026-2031)
3.2.2 Global Fungal (1-3)-β-D Glucan Detection Kit Revenue Forecast by Type (2026-2031)
3.2.3 Global Fungal (1-3)-β-D Glucan Detection Kit Price Forecast by Type (2026-2031)
3.3 Different Types Fungal (1-3)-β-D Glucan Detection Kit Representative Players
4 Global Market Size by Application
4.1 Global Fungal (1-3)-β-D Glucan Detection Kit Historic Market Review by Application (2020-2025)
4.1.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales by Application (2020-2025)
4.1.2 Global Fungal (1-3)-β-D Glucan Detection Kit Revenue by Application (2020-2025)
4.1.3 Global Fungal (1-3)-β-D Glucan Detection Kit Price by Application (2020-2025)
4.2 Global Fungal (1-3)-β-D Glucan Detection Kit Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales Forecast by Application (2026-2031)
4.2.2 Global Fungal (1-3)-β-D Glucan Detection Kit Revenue Forecast by Application (2026-2031)
4.2.3 Global Fungal (1-3)-β-D Glucan Detection Kit Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Fungal (1-3)-β-D Glucan Detection Kit Application
5 Competition Landscape by Players
5.1 Global Fungal (1-3)-β-D Glucan Detection Kit Sales by Players (2020-2025)
5.2 Global Top Fungal (1-3)-β-D Glucan Detection Kit Players by Revenue (2020-2025)
5.3 Global Fungal (1-3)-β-D Glucan Detection Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fungal (1-3)-β-D Glucan Detection Kit as of 2024)
5.4 Global Fungal (1-3)-β-D Glucan Detection Kit Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Fungal (1-3)-β-D Glucan Detection Kit, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Fungal (1-3)-β-D Glucan Detection Kit, Product Type & Application
5.7 Global Key Manufacturers of Fungal (1-3)-β-D Glucan Detection Kit, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Fungal (1-3)-β-D Glucan Detection Kit Sales by Company
6.1.1.1 North America Fungal (1-3)-β-D Glucan Detection Kit Sales by Company (2020-2025)
6.1.1.2 North America Fungal (1-3)-β-D Glucan Detection Kit Revenue by Company (2020-2025)
6.1.2 North America Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Type (2020-2025)
6.1.3 North America Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Application (2020-2025)
6.1.4 North America Fungal (1-3)-β-D Glucan Detection Kit Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Fungal (1-3)-β-D Glucan Detection Kit Sales by Company
6.2.1.1 Europe Fungal (1-3)-β-D Glucan Detection Kit Sales by Company (2020-2025)
6.2.1.2 Europe Fungal (1-3)-β-D Glucan Detection Kit Revenue by Company (2020-2025)
6.2.2 Europe Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Type (2020-2025)
6.2.3 Europe Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Application (2020-2025)
6.2.4 Europe Fungal (1-3)-β-D Glucan Detection Kit Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Fungal (1-3)-β-D Glucan Detection Kit Sales by Company
6.3.1.1 China Fungal (1-3)-β-D Glucan Detection Kit Sales by Company (2020-2025)
6.3.1.2 China Fungal (1-3)-β-D Glucan Detection Kit Revenue by Company (2020-2025)
6.3.2 China Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Type (2020-2025)
6.3.3 China Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Application (2020-2025)
6.3.4 China Fungal (1-3)-β-D Glucan Detection Kit Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Fungal (1-3)-β-D Glucan Detection Kit Sales by Company
6.4.1.1 Japan Fungal (1-3)-β-D Glucan Detection Kit Sales by Company (2020-2025)
6.4.1.2 Japan Fungal (1-3)-β-D Glucan Detection Kit Revenue by Company (2020-2025)
6.4.2 Japan Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Type (2020-2025)
6.4.3 Japan Fungal (1-3)-β-D Glucan Detection Kit Sales Breakdown by Application (2020-2025)
6.4.4 Japan Fungal (1-3)-β-D Glucan Detection Kit Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 Associates of Cape Cod
7.1.1 Associates of Cape Cod Company Information
7.1.2 Associates of Cape Cod Business Overview
7.1.3 Associates of Cape Cod Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.1.4 Associates of Cape Cod Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.1.5 Associates of Cape Cod Recent Development
7.2 Era Biology
7.2.1 Era Biology Company Information
7.2.2 Era Biology Business Overview
7.2.3 Era Biology Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.2.4 Era Biology Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.2.5 Era Biology Recent Development
7.3 Dynamiker Biotechnology
7.3.1 Dynamiker Biotechnology Company Information
7.3.2 Dynamiker Biotechnology Business Overview
7.3.3 Dynamiker Biotechnology Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Dynamiker Biotechnology Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.3.5 Dynamiker Biotechnology Recent Development
7.4 Zhanjiang A&C Biological
7.4.1 Zhanjiang A&C Biological Company Information
7.4.2 Zhanjiang A&C Biological Business Overview
7.4.3 Zhanjiang A&C Biological Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Zhanjiang A&C Biological Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.4.5 Zhanjiang A&C Biological Recent Development
7.5 Xiamen Bioendo Technology
7.5.1 Xiamen Bioendo Technology Company Information
7.5.2 Xiamen Bioendo Technology Business Overview
7.5.3 Xiamen Bioendo Technology Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Xiamen Bioendo Technology Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.5.5 Xiamen Bioendo Technology Recent Development
7.6 Zhanjiang Bokang Marine Biological
7.6.1 Zhanjiang Bokang Marine Biological Company Information
7.6.2 Zhanjiang Bokang Marine Biological Business Overview
7.6.3 Zhanjiang Bokang Marine Biological Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Zhanjiang Bokang Marine Biological Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.6.5 Zhanjiang Bokang Marine Biological Recent Development
7.7 Fuzhou XinBei Biochemical Industrial
7.7.1 Fuzhou XinBei Biochemical Industrial Company Information
7.7.2 Fuzhou XinBei Biochemical Industrial Business Overview
7.7.3 Fuzhou XinBei Biochemical Industrial Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.7.4 Fuzhou XinBei Biochemical Industrial Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.7.5 Fuzhou XinBei Biochemical Industrial Recent Development
7.8 Zhuhai DL Biotech
7.8.1 Zhuhai DL Biotech Company Information
7.8.2 Zhuhai DL Biotech Business Overview
7.8.3 Zhuhai DL Biotech Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Zhuhai DL Biotech Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.8.5 Zhuhai DL Biotech Recent Development
7.9 Autobio Diagnostics
7.9.1 Autobio Diagnostics Company Information
7.9.2 Autobio Diagnostics Business Overview
7.9.3 Autobio Diagnostics Fungal (1-3)-β-D Glucan Detection Kit Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Autobio Diagnostics Fungal (1-3)-β-D Glucan Detection Kit Products Offered
7.9.5 Autobio Diagnostics Recent Development
8 Fungal (1-3)-β-D Glucan Detection Kit Manufacturing Cost Analysis
8.1 Fungal (1-3)-β-D Glucan Detection Kit Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Fungal (1-3)-β-D Glucan Detection Kit
8.4 Fungal (1-3)-β-D Glucan Detection Kit Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Fungal (1-3)-β-D Glucan Detection Kit Distributors List
9.3 Fungal (1-3)-β-D Glucan Detection Kit Customers
10 Fungal (1-3)-β-D Glucan Detection Kit Market Dynamics
10.1 Fungal (1-3)-β-D Glucan Detection Kit Industry Trends
10.2 Fungal (1-3)-β-D Glucan Detection Kit Market Drivers
10.3 Fungal (1-3)-β-D Glucan Detection Kit Market Challenges
10.4 Fungal (1-3)-β-D Glucan Detection Kit Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fungal (1-3)-β-D Glucan Detection Kit market is projected to grow from US$ 61.88 million in 2025 to US$ 152 million by 2032, at a CAGR of 13.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 133
USD 4900.00
(Single User License)
The global Fungal (1-3)-β-D Glucan Detection Kit market size was US$ 61.88 million in 2025 and is forecast to reach a readjusted size of US$ 152 million by 2032 with a CAGR of 13.9% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 78
USD 4250.00
(Single User License)
The global market for Fungal (1-3)-β-D Glucan Detection Kit was estimated to be worth US$ 61.88 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 13.9% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 106
USD 3950.00
(Single User License)
The global Fungal (1-3)-β-D Glucan Detection Kit market was valued at US$ 61.88 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 13.9% from 2026 to 2032.
Published Date: 2026-01-16
Pages: 108
USD 2900.00
(Single User License)
The global Fungal (1-3)-β-D Glucan Detection Kit market is projected to grow from US$ 55 million in 2024 to US$ 135 million by 2031, at a CAGR of 13.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 131
USD 4900.00
(Single User License)
The global market for Fungal (1-3)-β-D Glucan Detection Kit was estimated to be worth US$ 55 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 13.9% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 103
USD 3950.00
(Single User License)
The global market for Fungal (1-3)-β-D Glucan Detection Kit was valued at US$ 55 million in the year 2024 and is projected to reach a revised size of US$ 135 million by 2031, growing at a CAGR of 13.9% during the forecast period.
Published Date: 2025-03-10
Pages: 87
USD 2900.00
(Single User License)
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
Published Date: 2024-03-15
Pages: 110
USD 4350.00
(Single User License)
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
Published Date: 2024-03-15
Pages: 130
USD 4900.00
(Single User License)
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
Published Date: 2024-03-15
Pages: 110
USD 3950.00
(Single User License)
The global Fungal (1-3)-β-D Glucan Detection Kit market is projected to grow from US$ 61.88 million in 2025 to US$ 152 million by 2032, at a CAGR of 13.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 133
The global Fungal (1-3)-β-D Glucan Detection Kit market size was US$ 61.88 million in 2025 and is forecast to reach a readjusted size of US$ 152 million by 2032 with a CAGR of 13.9% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 78
The global market for Fungal (1-3)-β-D Glucan Detection Kit was estimated to be worth US$ 61.88 million in 2025 and is projected to reach US$ 152 million, growing at a CAGR of 13.9% from 2026 to 2032.
Published: 2026-01-19
Pages: 106
The global Fungal (1-3)-β-D Glucan Detection Kit market was valued at US$ 61.88 million in 2025 and is anticipated to reach US$ 152 million by 2032, at a CAGR of 13.9% from 2026 to 2032.
Published: 2026-01-16
Pages: 108
The global Fungal (1-3)-β-D Glucan Detection Kit market is projected to grow from US$ 55 million in 2024 to US$ 135 million by 2031, at a CAGR of 13.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 131
The global market for Fungal (1-3)-β-D Glucan Detection Kit was estimated to be worth US$ 55 million in 2024 and is forecast to a readjusted size of US$ 135 million by 2031 with a CAGR of 13.9% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 103
The global market for Fungal (1-3)-β-D Glucan Detection Kit was valued at US$ 55 million in the year 2024 and is projected to reach a revised size of US$ 135 million by 2031, growing at a CAGR of 13.9% during the forecast period.
Published: 2025-03-10
Pages: 87
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
Published: 2024-03-15
Pages: 110
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
Published: 2024-03-15
Pages: 130
"Invasive candidiasis is an infection caused by a yeast (a type of fungus) called Candida. Unlike Candida infections in the mouth and throat (also called “thrush”) or vaginal “yeast infections,” invasive candidiasis is a serious infection that can affect the blood, heart, brain, eyes, bones, and other parts of the body. Candidemia, a bloodstream infection with Candida, is a common infection in hospitalized patients. At present, most hospitals are carrying out non-invasive laboratory diagnosis techniques such as G test and GM test."
Published: 2024-03-15
Pages: 110
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now